Journal of Clinical Immunology

, Volume 35, Issue 6, pp 531–537 | Cite as

Pregnancy Outcome in Patients with Common Variable Immunodeficiency

  • Pavlina Kralickova
  • Barbora Kurecova
  • Ctirad Andrys
  • Irena Krcmova
  • Dalibor Jilek
  • Marcela Vlkova
  • Jiri Litzman



The aim of our retrospective study was to clarify fertility, pregnancy complications and outcomes in common variable immunodeficiency (CVID) females.


Retrospective data were obtained from three Czech referral centres. The data were compared with data obtained from the Czech National Registry of Reproduction Health.


Our cohort of patients comprised 54 women with 115 pregnancies; 88 pregnancies in 50 females were finished with live births (77 %). In only 8 women (15 %) was the diagnosis of CVID established before the first pregnancy. Replacement immunoglobulin therapy was performed in 10 patients without any moderate or severe adverse effects. Compared with the Czech population, the CVID patients suffered significantly more frequently from the threat of preterm labour (p < 0.0001), vaginal bleeding (p = 0.0001), eclampsia/preeclampsia (p = 0.009) and a higher number of stillbirths (p < 0.0001). Furthermore, the frequency of babies with low birth weight (less than 2500 g) born to the CVID patients was increased compared with the normal population (p < 0.0001). Serum IgG, IgA and IgM determination was done in 57 children of 50 mothers showing 13 cases of IgA deficiency (23 %). There was no significant difference among the non-symptomatic, symptomatic untreated and symptomatic treated females in any of the determined gynaecological complications. The number of unsuccessful pregnancies was higher in the symptomatic untreated women.


Fertility in CVID patients is not decreased, and their pregnancies could be considered more risky compared with those of the general population.


CVID fertility pregnancy replacement therapy 



Supported by a grant awarded by the Czech Ministry of Health, Czech Republic (NT13271/2012) and by the project “Employment of Newly Graduated Doctors of Science for Scientific Excellence” (CZ.1.07/2.3.00/30.0009) co-financed from European Social Fund and the state budget of the Czech Republic.

Conflict of Interest

The authors have no conflict of interest to disclose.


  1. 1.
    Conley ME, Notarangelo LD, Etzioni A. Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies). Clin Immunol. 1999;93:190–7.CrossRefPubMedGoogle Scholar
  2. 2.
    Resnick ES, Moshier EL, Godbold JH, Cunningham-Rundles C. Morbidity and mortality in common variable immune deficiency over 4 decades. Blood. 2012;119:1650–7.PubMedCentralCrossRefPubMedGoogle Scholar
  3. 3.
    Quinti I, Soresina A, Spadaro G, Martino S, Donnanno S, Agostini C, et al. Long-term follow-up and outcome of a large cohort of patients with common variable immunodeficiency. J Clin Immunol. 2007;27:308–16.CrossRefPubMedGoogle Scholar
  4. 4.
    Shalev E, Ben-Ami M, Peleg D. Common variable hypogammaglobulinemia in pregnancy. Br J Obstet Gynaecol. 1993;100:1138–40.CrossRefPubMedGoogle Scholar
  5. 5.
    Gundlapalli AV, Scalchunes C, Boyle M, Hill HR. Fertility, pregnancies and outcomes reported by females with common variable immune deficiency and hypogammaglobulinemia: results from an internet-based survey. J Clin Immunol. 2015;35:125–34.PubMedCentralCrossRefPubMedGoogle Scholar
  6. 6.
    Zpráva o matce a dítěti. Mother and newborn 2012. Accessed 20 Jan 2015.
  7. 7.
    Potraty v roce 2012. Abortions 2012. 2012. Accessed 20 Jan 2015.
  8. 8.
    Fencl F, Malina M, Stara V, Zieg J, Mixova D, Seeman T, et al. Discordant expression of a new WT1 gene mutation in a family with monozygotic twins presenting with congenital nephrotic syndrome. Eur J Pediatr. 2012;171:121–4.CrossRefPubMedGoogle Scholar
  9. 9.
    Laursen HB, Christensen MF. Immunoglobulins in normal infant born of severe hypo-gamma-globulinaemic mother. Arch Dis Child. 1973;48:646–8.PubMedCentralCrossRefPubMedGoogle Scholar
  10. 10.
    Williams PE, Leen CL, Heppleston AD, Yap PL. IgG replacement therapy for primary hypogammaglobulinaemia during pregnancy: report of 9 pregnancies in 4 patients. Blut. 1990;60:198–201.CrossRefPubMedGoogle Scholar
  11. 11.
    Zak SJ, Good RA. Immunochemical studies of human serum gamma globulins. J Clin Invest. 1959;38:579–86.PubMedCentralCrossRefPubMedGoogle Scholar
  12. 12.
    Bridges RA, Condie RM, Zak SJ, Good RA. The morphologic basis of antibody formation development during the neonatal period. J Lab Clin Med. 1959;53:331–57.PubMedGoogle Scholar
  13. 13.
    Holland NH, Holland P. Immunological maturation in an infant of an agammaglobulinaemic mother. Lancet. 1966;2:1152–5.CrossRefPubMedGoogle Scholar
  14. 14.
    Berger M, Cupps TR, Fauci AS. High-dose immunoglobulin replacement therapy by slow subcutaneous infusion during pregnancy. JAMA. 1982;247:2824–5.CrossRefPubMedGoogle Scholar
  15. 15.
    Malek A, Sager R, Kuhn P, Nicolaides KH, Schneider H. Evolution of maternofetal transport of immunoglobulins during human pregnancy. Am J Reprod Immunol. 1996;36:248–55.CrossRefPubMedGoogle Scholar
  16. 16.
    Kohler PF, Farr RS. Elevation of cord over maternal IgG immunoglobulin: evidence for an active placental IgG transport. Nature. 1966;210:1070–1.CrossRefPubMedGoogle Scholar
  17. 17.
    Pitcher-Wilmott RW, Hindocha P, Wood CB. The placental transfer of IgG subclasses in human pregnancy. Clin Exp Immunol. 1980;41:303–8.PubMedCentralPubMedGoogle Scholar
  18. 18.
    Gardulf A, Andersson E, Lindqvist M, Hansen S, Gustafson R. Rapid subcutaneous IgG replacement therapy at home for pregnant immunodeficient women. J Clin Immunol. 2001;21:150–4.CrossRefPubMedGoogle Scholar
  19. 19.
    Funakoshi N, Ohno T, Kanoh T, Uchino H, Miyake T, Oda T, et al. Agammaglobulinemia in a pregnant woman. Tohoku J Exp Med. 1986;149:359–65.CrossRefPubMedGoogle Scholar
  20. 20.
    Madsen DL, Catanzarite VA, Varela-Gittings F. Common variable hypogammaglobulinemia in pregnancy: treatment with high-dose immunoglobulin infusions. Am J Hematol. 1986;21:327–9.CrossRefPubMedGoogle Scholar
  21. 21.
    Osada H, Morikawa Y, Nishiwaki T, Sekiya S. Intravenous immunoglobulin replacement therapy for common variable immunodeficiency during pregnancy. Arch Gynecol Obstet. 1996;258:155–9.CrossRefPubMedGoogle Scholar
  22. 22.
    Sorensen RU, Tomford JW, Gyves MT, Judge NE, Polmar SH. Use of intravenous immune globulin in pregnant women with common variable hypogammaglobulinemia. Am J Med. 1984;76:73–7.CrossRefPubMedGoogle Scholar
  23. 23.
    Brinker KA, Silk HJ. Common variable immune deficiency and treatment with intravenous immunoglobulin during pregnancy. Ann Allergy Asthma Immunol. 2012;108:464–5.CrossRefPubMedGoogle Scholar
  24. 24.
    Danieli MB, Moretti R, Pettinari L, Gambini S. Management of a pregnant woman with common variable immunodeficiency and previous reactions to intravenous IgG administration. BMJ Case Rep. 2012. doi: 10.1136/bcr-2012-007594.Google Scholar
  25. 25.
    Schaffer FM, Newton MDIA. Intravenous gamma globulin administration to common variable immunodeficient women during pregnancy: case report and review of literature. J Perinatol. 1994;14:114–7.PubMedGoogle Scholar
  26. 26.
    Vorechovsky I, Webster AD, Plebani A, Hammarstrom L. Genetic linkage of IgA deficiency to the major histocompatibility complex: evidence for allele segregation distortion, parent-of-origin penetrance differences, and the role of anti-IgA antibodies in disease predisposition. Am J Hum Genet. 1999;64:1096–109.PubMedCentralCrossRefPubMedGoogle Scholar
  27. 27.
    Litzman J, Sevcikova I, Stikarovska D, Pikulova Z, Pazdirkova A, Lokaj J. IgA deficiency in Czech healthy individuals and selected patient groups. Int Arch Allergy Immunol. 2000;123:177–80.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2015

Authors and Affiliations

  • Pavlina Kralickova
    • 1
  • Barbora Kurecova
    • 2
  • Ctirad Andrys
    • 1
  • Irena Krcmova
    • 1
  • Dalibor Jilek
    • 3
  • Marcela Vlkova
    • 4
    • 5
  • Jiri Litzman
    • 4
    • 5
  1. 1.Institute of Clinical Immunology and AllergologyUniversity HospitalHradec KraloveCzech Republic
  2. 2.Reprofit International, s.r.o.BrnoCzech Republic
  3. 3.Centre of Immunology and MicrobiologyRegional Institute of Public HealthUsti nad LabemCzech Republic
  4. 4.Departmant of Clinical Immunology and AllergologySt. Anne’s University HospitalBrnoCzech Republic
  5. 5.Department of Clinical Immunology and Allergology, Faculty of MedicineMasaryk UniversityBrnoCzech Republic

Personalised recommendations